11 Mar 2026
NSAIDs-loaded nanocarriers as emerging anticancer therapeutics: Harnessing inflammation-targeted drug delivery to combat tumor progressionPublisher siteInternational Journal of Pharmaceutics, Graphene and Nanomaterials Applications
UniversitiesMaha M. Amin
Active, last published 2026
Maha M.
Amin
Scholar“Research profile drawn from open scholarly records.”
Cairo University
Claim Your Profile0
H-index
0
Citations
Maha has not officially claimed their profile. If you are Maha, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Maha M. Amin will appear here once their profile is updated.
02 · Reach
Publication output and reach
Maha's work has been cited 0 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchCairo UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
3 works5 Nov 2025
A nanoparticle strategy to repurpose naringenin: Enhancing oral bioavailability via lipid conjugation unlocks potent antituberculosis activityPublisher siteJournal of Drug Delivery Science and Technology, Advancements in Transdermal Drug Delivery
1 Jul 2024Open access
Type I or Type II Endometrial Carcinoma? Role of BRCA1 ImmunohistochemistryPublisher siteAsian Pacific Journal of Cancer Prevention, Ovarian cancer diagnosis and treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Maha?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you